29th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma 2025

The 29th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma 2025 is dedicated to the clinician application of the wealth of emerging data in treating hematologic malignancies with a focus on leukemias, lymphomas and myeloma.

The 29th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma 2025 covers topics such as:

• Acute myeloid leukemia
• Acute lymphoblastic leukemia
• Chronic myeloid leukemia
• Chronic lymphocytic leukemia
• Non-Hodgkin lymphoma
• Hodgkin lymphoma
• Myelodysplastic syndromes
• Multiple myeloma
• Other blood cell disorders, including ITP
• Myeloproliferative neoplasms
• Other, including preclinical studies

The 29th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma 2025 brings together oncologists and other healthcare professionals.